Domenica Lovero1, Stella D'Oronzo1, Raffaele Palmirotta1, Paola Cafforio1, Janet Brown2, Steven Wood2, Camillo Porta1, Eleonora Lauricella1, Robert Coleman2, Franco Silvestris3. 1. Department of Biomedical Sciences and Human Oncology-Section of Internal Medicine and Clinical Oncology, University of Bari Aldo Moro, Bari, Italy. 2. Department of Oncology and Metabolism, University of Sheffield, Weston Park Hospital, Sheffield, UK. 3. Department of Biomedical Sciences and Human Oncology-Section of Internal Medicine and Clinical Oncology, University of Bari Aldo Moro, Bari, Italy. francosilvestris@gmail.com.
Abstract
BACKGROUND: Bone is the most frequent site of metastases from breast cancer (BC), but no biomarkers are yet available to predict skeletal dissemination. METHODS: We attempted to identify a gene signature correlated with bone metastasis (BM) onset in circulating tumour cells (CTCs), isolated by a DEPArray-based protocol from 40 metastatic BC patients and grouped according to metastasis sites, namely "BM" (bone-only), "ES" (extra-skeletal) or BM + ES (bone + extra-skeletal). RESULTS: A 134-gene panel was first validated through targeted RNA sequencing (RNAseq) on sub-clones of the MDA-MB-231 BC cell line with variable organotropism, which successfully shaped their clustering. The panel was then applied to CTC groups and, in particular, the "BM" vs "ES" CTC comparison revealed 31 differentially expressed genes, including MAF, CAPG, GIPC1 and IL1B, playing key prognostic roles in BC. CONCLUSION: Such evidence confirms that CTCs are suitable biological sources for organotropism investigation through targeted RNAseq and might deserve future applications in wide-scale prospective studies.
BACKGROUND: Bone is the most frequent site of metastases from breast cancer (BC), but no biomarkers are yet available to predict skeletal dissemination. METHODS: We attempted to identify a gene signature correlated with bone metastasis (BM) onset in circulating tumour cells (CTCs), isolated by a DEPArray-based protocol from 40 metastatic BC patients and grouped according to metastasis sites, namely "BM" (bone-only), "ES" (extra-skeletal) or BM + ES (bone + extra-skeletal). RESULTS: A 134-gene panel was first validated through targeted RNA sequencing (RNAseq) on sub-clones of the MDA-MB-231 BC cell line with variable organotropism, which successfully shaped their clustering. The panel was then applied to CTC groups and, in particular, the "BM" vs "ES" CTC comparison revealed 31 differentially expressed genes, including MAF, CAPG, GIPC1 and IL1B, playing key prognostic roles in BC. CONCLUSION: Such evidence confirms that CTCs are suitable biological sources for organotropism investigation through targeted RNAseq and might deserve future applications in wide-scale prospective studies.
Authors: Bernardo Amadeo Leone; Carlos Teodoro Vallejo; Alberto Omar Romero; Mario Raúl Machiavelli; Juan Eduardo Pérez; Julieta Leone; José Pablo Leone Journal: Breast Cancer Res Treat Date: 2016-12-14 Impact factor: 4.872
Authors: Massimo Cristofanilli; Jean-Yves Pierga; James Reuben; Alfred Rademaker; Andrew A Davis; Dieter J Peeters; Tanja Fehm; Franco Nolé; Rafael Gisbert-Criado; Dimitrios Mavroudis; Salvatore Grisanti; Mario Giuliano; Jose A Garcia-Saenz; Justin Stebbing; Carlos Caldas; Paola Gazzaniga; Luis Manso; Rita Zamarchi; Angela Fernandez de Lascoiti; Leticia De Mattos-Arruda; Michail Ignatiadis; Luc Cabel; Steven J van Laere; Franziska Meier-Stiegen; Maria-Teresa Sandri; Jose Vidal-Martinez; Eleni Politaki; Francesca Consoli; Daniele Generali; Maria Rosa Cappelletti; Eduardo Diaz-Rubio; Jonathan Krell; Sarah-Jane Dawson; Cristina Raimondi; Annemie Rutten; Wolfgang Janni; Elisabetta Munzone; Vicente Carañana; Sofia Agelaki; Camillo Almici; Luc Dirix; Erich-Franz Solomayer; Laura Zorzino; Lauren Darrigues; Jorge S Reis-Filho; Lorenzo Gerratana; Stefan Michiels; François-Clément Bidard; Klaus Pantel Journal: Crit Rev Oncol Hematol Date: 2018-12-19 Impact factor: 6.312
Authors: Yibin Kang; Peter M Siegel; Weiping Shu; Maria Drobnjak; Sanna M Kakonen; Carlos Cordón-Cardo; Theresa A Guise; Joan Massagué Journal: Cancer Cell Date: 2003-06 Impact factor: 31.743
Authors: Daniel Brian Shropshire; Francisca M Acosta; Kun Fang; Jaime Benavides; Lu-Zhe Sun; Victor X Jin; Jean X Jiang Journal: Front Med (Lausanne) Date: 2022-09-15